pharmacopeia

Nephrolithiasis

12 drugs1,932 FAERS reportsMedDRA PT
GET
/api/v1/reaction/nephrolithiasis
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D053040

Formation of stones in the KIDNEY.

Source: U.S. National Library of Medicine — MeSH (Nephrolithiasis)

Drugs reporting Nephrolithiasis (12)

Share = reports listing this reaction ÷ total matched reports for the drug. means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Relacorilant133%
  2. 2Almotriptan29431%
  3. 3Dihydroergotamine19316%
  4. 4Gluconolactone212%
  5. 5Lumasiran349.8%
  6. 6Chlorcyclizine27.4%
  7. 7Potassium Citrate2735.1%
  8. 8Marstacimab23.9%
  9. 9Tiopronin913.8%
  10. 10Atazanavir4733.3%
  11. 11Ketamine1483.2%
  12. 12Rizatriptan4192.7%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Nephrolithiasis as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients